A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia

Elizabeth A. Griffiths^*, William E. Brady, Wei Tan, Carlos E. Vigil, James E. Thompson, Laurie A. Ford, Noelle M. Dickey, Heather L. Bashaw, Jill Sperrazza, Meir Wetzler, Eunice S. Wang

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review